Treatment in 2nd Line Setting After 1st Line PD-L1 Targeting

Treatment in 2nd Line Setting After 1st Line PD-L1 Targeting

obr

8 months
173 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Ravi Salgia, MD, Professor and Chair, Department of Medical Oncology and Therapeutics Research, Associate Director for Clinical Sciences, Arthur and Rosalie Kaplan Endowed Chair in Medical Oncology, City of Hope, explains how 2nd line patients who received Keytruda or other PD-L1 targeting agents can be treated.
Up Next Autoplay